OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Rheumatology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Update on antineutrophil cytoplasmic autoantibody vasculitis in children	102
Current views on lupus in children	65
Urticarial vasculitis	54
Editorial introduction	54
Giant cell arteritis: update on pathogenesis and clinical implications	45
Current approach to muscle imaging in myositis	42
Polymyalgia rheumatica and giant cell arteritis: diagnosis and management	42
Editorial introductions	32
Optimizing reproductive health management in lupus and Sjogren's syndrome	32
Osteoporosis epidemiology using international cohorts	30
The safety of glucocorticoids in the treatment of inflammatory rheumatic disease: new evidence	29
Juvenile Behçet syndrome: a contemporary view and differential diagnosis in pediatric practice	28
Axial spondyloarthritis guidelines – aiming for maximum impact	28
Rheumatoid arthritis – the challenge of heterogeneity	28
The gut microbiota in spondyloarthritis: an update	25
Editorial introductions	24
Recent advances in the use of machine learning and artificial intelligence to improve diagnosis, predict flares, and enrich clinical trials in lupus	24
Composite measures to assess disease damage, disease severity and treatment response in systemic sclerosis clinical trials	24
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis	23
Ribosome dysfunction in osteoarthritis	22
Updates on translational and clinical research in systemic sclerosis	22
VEXAS syndrome: an adult-onset autoinflammatory disorder with underlying somatic mutation	21
Understanding the gastrointestinal microbiome in systemic sclerosis: methodological advancements and emerging research	21
Update on gout management: what is old and what is new	21
Editorial introduction	20

Editorial introductions	17
Defining and managing flares in axial spondyloarthritis	17
The role of neutrophil extracellular traps in inflammatory rheumatic diseases	16
Emerging synovial cell states in rheumatoid arthritis as potential therapeutic targets	16
Epidemiology of myositis	16
Haematopoietic stem cell transplantation in paediatric rheumatic disease	16
Insights into the pathogenic role of neutrophils in systemic lupus erythematosus	16
Health inequities in the rheumatic diseases of childhood	16
Management of cutaneous manifestations of systemic sclerosis: current approaches and emerging therapies	16
Biomarkers in systemic sclerosis: mechanistic insights into pathogenesis and treatment	16
Editorial introductions	16
Gout and the COVID-19 pandemic	15
Pathogenesis of vasculopathy in systemic sclerosis and its contribution to fibrosis	14
Animal models of vasculitis	14
Raynaud's phenomenon and digital ulcers: advances in evaluation and management	14
Chimeric antigen receptor T-cell therapy in rheumatology: B-cell depletion 2.0	13
Nonsteroidal anti-inflammatory drugs and cardiovascular disease risk in spondyloarthritis-spectrum diseases	13
Is it time to move on from pelvic radiography as the first-line imaging modality for suspected sacroiliitis?	13
Inflammatory back pain: a concept, not a diagnosis	12
Biomarker discovery in psoriatic disease	12
Polymyositis: does it really exist as a distinct clinical subset?	11
Editorial introductions	11
Insights into origins and specificities of autoantibodies in systemic sclerosis	11
New developments related to lung complications in pediatric rheumatic disease	11
AI am the future: artificial intelligence in pediatric rheumatology	11
Editorial introductions	11
Heart involvement in systemic sclerosis: emerging concepts	10
Exploring challenges in the management and treatment of inclusion body myositis	10
Editorial introduction	10
Emerging biologic therapies for systemic lupus erythematosus	10
Diagnosis and management of primary heart involvement in systemic sclerosis	10
Insights into the molecular landscape of osteoarthritis in human tissues	10
Investigating gout flares: beyond a definition	10
The contribution of endothelial cells to tissue fibrosis	9
Environmental triggers for connective tissue disease: the case of COVID-19 associated with dermatomyositis-specific autoantibodies	9
Epidemiology of osteoarthritis: literature update 2022–2023	9
Gastrointestinal disease in systemic sclerosis: the neglected organ system?	9
Current management of giant cell arteritis and its complications	9
Vasculitis and the NLRP3 inflammasome	9
Management of postinfectious inflammatory arthritis	9
Contribution of monocytes and macrophages to the pathogenesis of systemic sclerosis: recent insights and therapeutic implications	9
Animal models in systemic sclerosis: an update	9
The association of Behçet's syndrome with HLA-B51 as understood in 2021	9